These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 34899860)

  • 21. Efficacy and safety of flecainide for ventricular arrhythmias in patients with Andersen-Tawil syndrome with KCNJ2 mutations.
    Miyamoto K; Aiba T; Kimura H; Hayashi H; Ohno S; Yasuoka C; Tanioka Y; Tsuchiya T; Yoshida Y; Hayashi H; Tsuboi I; Nakajima I; Ishibashi K; Okamura H; Noda T; Ishihara M; Anzai T; Yasuda S; Miyamoto Y; Kamakura S; Kusano K; Ogawa H; Horie M; Shimizu W
    Heart Rhythm; 2015 Mar; 12(3):596-603. PubMed ID: 25496985
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Andersen-Tawil syndrome: Clinical presentation and predictors of symptomatic arrhythmias - Possible role of polymorphisms K897T in KCNH2 and H558R in SCN5A gene.
    Krych M; Biernacka EK; Ponińska J; Kukla P; Filipecki A; Gajda R; Hasdemir C; Antzelevitch C; Kosiec A; Szperl M; Płoski R; Trusz-Gluza M; Mizia-Stec K; Hoffman P
    J Cardiol; 2017 Nov; 70(5):504-510. PubMed ID: 28336205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genotypic heterogeneity and phenotypic mimicry among unrelated patients referred for catecholaminergic polymorphic ventricular tachycardia genetic testing.
    Tester DJ; Arya P; Will M; Haglund CM; Farley AL; Makielski JC; Ackerman MJ
    Heart Rhythm; 2006 Jul; 3(7):800-5. PubMed ID: 16818210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rarity and phenotypic heterogeneity provide challenges in the diagnosis of Andersen-Tawil syndrome: Two cases presenting with ECGs mimicking catecholaminergic polymorphic ventricular tachycardia (CPVT).
    Tully I; Atherton J; Hunt L; Ingles J; Semsarian C; McGaughran J
    Int J Cardiol; 2015 Dec; 201():473-5. PubMed ID: 26322597
    [No Abstract]   [Full Text] [Related]  

  • 25. Characterization of a novel, dominant negative KCNJ2 mutation associated with Andersen-Tawil syndrome.
    Marrus SB; Cuculich PS; Wang W; Nerbonne JM
    Channels (Austin); 2011; 5(6):500-9. PubMed ID: 22186697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of any cardiac involvement in a patient with Andersen-Tawil syndrome associated with the c.574A→G mutation in KCNJ2.
    Modoni A; Bianchi ML; Vitulano N; Pagliarani S; Perna F; Sanna T; Rizzo V; Silvestri G
    Cardiology; 2011; 120(4):200-3. PubMed ID: 22286118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of a novel KCNJ2 sequence variant detected in Andersen-Tawil syndrome patients.
    Scheiper S; Hertel B; Beckmann BM; Kääb S; Thiel G; Kauferstein S
    BMC Med Genet; 2017 Oct; 18(1):113. PubMed ID: 29017447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Andersen-Tawil Syndrome: A Comprehensive Review.
    Pérez-Riera AR; Barbosa-Barros R; Samesina N; Pastore CA; Scanavacca M; Daminello-Raimundo R; de Abreu LC; Nikus K; Brugada P
    Cardiol Rev; 2021 Jul-Aug 01; 29(4):165-177. PubMed ID: 32947483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations of KCNJ2 gene associated with Andersen-Tawil syndrome in Korean families.
    Choi BO; Kim J; Suh BC; Yu JS; Sunwoo IN; Kim SJ; Kim GH; Chung KW
    J Hum Genet; 2007; 52(3):280-283. PubMed ID: 17211524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a novel exon3 deletion of RYR2 in a family with catecholaminergic polymorphic ventricular tachycardia.
    Dharmawan T; Nakajima T; Ohno S; Iizuka T; Tamura S; Kaneko Y; Horie M; Kurabayashi M
    Ann Noninvasive Electrocardiol; 2019 May; 24(3):e12623. PubMed ID: 30615235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A new type of periodic paralysis: Andersen-Tawil syndrome].
    Pouget J
    Bull Acad Natl Med; 2008 Nov; 192(8):1551-6; discussion 1556-7. PubMed ID: 19445372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Andersen-Tawil syndrome: deep phenotyping reveals significant cardiac and neuromuscular morbidity.
    Vivekanandam V; Männikkö R; Skorupinska I; Germain L; Gray B; Wedderburn S; Kozyra D; Sud R; James N; Holmes S; Savvatis K; Fialho D; Merve A; Pattni J; Farrugia M; Behr ER; Marini-Bettolo C; Hanna MG; Matthews E
    Brain; 2022 Jun; 145(6):2108-2120. PubMed ID: 34919635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Obstetric management of a patient with Andersen-Tawil syndrome: A case report.
    Inagaki M; Tatsumi T; Yomogita H; Hirose A; Kubo T; Sekiguchi M; Miyasaka N
    J Obstet Gynaecol Res; 2021 Jan; 47(1):446-451. PubMed ID: 33205612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Marked reduction in paralytic attacks in a patient with Andersen-Tawil syndrome switched from acetazolamide to dichlorphenamide.
    Gupta A; Iyadurai S; Roggenbuck J; LoRusso S
    Neuromuscul Disord; 2021 Jul; 31(7):656-659. PubMed ID: 34078557
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Case report: Mexiletine suppresses ventricular arrhythmias in Andersen-Tawil syndrome.
    Yang J; Li K; Lv T; Xie Y; Liu F; Zhang P
    Front Cardiovasc Med; 2022; 9():992185. PubMed ID: 36093155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sudden cardiac death in Andersen-Tawil syndrome.
    Peters S; Schulze-Bahr E; Etheridge SP; Tristani-Firouzi M
    Europace; 2007 Mar; 9(3):162-6. PubMed ID: 17272325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenotypical variability and atypical presentations in a French cohort of Andersen-Tawil syndrome.
    Villar-Quiles RN; Sternberg D; Tredez G; Beatriz Romero N; Evangelista T; Lafôret P; Cintas P; Sole G; Sacconi S; Bendahhou S; Franques J; Cances C; Noury JB; Delmont E; Blondy P; Perrin L; Hezode M; Fournier E; Fontaine B; Stojkovic T; Vicart S
    Eur J Neurol; 2022 Aug; 29(8):2398-2411. PubMed ID: 35460302
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plakophilin-2 Truncation Variants in Patients Clinically Diagnosed With Catecholaminergic Polymorphic Ventricular Tachycardia and Decedents With Exercise-Associated Autopsy Negative Sudden Unexplained Death in the Young.
    Tester DJ; Ackerman JP; Giudicessi JR; Ackerman NC; Cerrone M; Delmar M; Ackerman MJ
    JACC Clin Electrophysiol; 2019 Jan; 5(1):120-127. PubMed ID: 30678776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electrophysiological mechanisms of ventricular arrhythmias in relation to Andersen-Tawil syndrome under conditions of reduced IK1: a simulation study.
    Sung RJ; Wu SN; Wu JS; Chang HD; Luo CH
    Am J Physiol Heart Circ Physiol; 2006 Dec; 291(6):H2597-605. PubMed ID: 16877549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non dominant-negative KCNJ2 gene mutations leading to Andersen-Tawil syndrome with an isolated cardiac phenotype.
    Limberg MM; Zumhagen S; Netter MF; Coffey AJ; Grace A; Rogers J; Böckelmann D; Rinné S; Stallmeyer B; Decher N; Schulze-Bahr E
    Basic Res Cardiol; 2013 May; 108(3):353. PubMed ID: 23644778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.